-
Mashup Score: 0
Iopofosine I 131 generated a major response rate of 56.4% in patients with relapsed/refractory Waldenström macroglobulinemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1FDA Accepts Resubmission of BLA for Remestemcel-L in Pediatric Steroid-Refractory aGVHD - 6 month(s) ago
The FDA has accepted the resubmission of a BLA for remestemcel-L in pediatric steroid-refractory acute graft-vs-host-disease.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
FDA Accepts Resubmission of BLA for Remestemcel-L in Pediatric Steroid-Refractory aGVHD @US_FDA #hematology #oncology https://t.co/XKOAFNx60X
-
-
Mashup Score: 3
Jeremy Allred, MD, details current and emerging treatments for patients with myelodysplastic syndrome, highlighting recent key data updates.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Jeremy Allred, MD, details current and emerging treatments for patients with myelodysplastic syndrome, highlighting recent key data updates. @umnmedschool #hematology #oncology https://t.co/CkHhBQ6Nkq
-
-
Mashup Score: 3
Jeremy Allred, MD, details current and emerging treatments for patients with myelodysplastic syndrome, highlighting recent key data updates.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Jeremy Allred, MD, details current and emerging treatments for patients with myelodysplastic syndrome, highlighting recent key data updates. @umnmedschool #hematology #oncology https://t.co/CkHhBQ6Nkq
-
-
Mashup Score: 2Call for Boxed Warning for Secondary Malignancies on CAR T-Cell Therapies Raises Alarm, But Key Questions Remain - 9 month(s) ago
Experts discuss the FDA’s call for a boxed warning for secondary T-cell malignancies on all approved CAR T-cell agents in late January 2024.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Call for Boxed Warning for Secondary Malignancies on CAR T-Cell Therapies Raises Alarm, But Key Questions Remain #hematology #oncology https://t.co/fdPlv3dmLQ
-
-
Mashup Score: 3
Mikkael A. Sekeres, MD, MS, discusses the utility of myelodysplastic syndromes risk stratification systems.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Hear from @MikkaelSekeres, of @SylvesterCancer, as he discusses the utility of myelodysplastic syndromes risk stratification systems. #hematology #oncology https://t.co/j3RLz3RQuf
-
-
Mashup Score: 1833rd Annual Mayo Clinic Hematology/Oncology Reviews 2024 | Mayo Clinic School of Continuous Professional Development - 10 month(s) ago
July 25 – 27, 2024 – The Ritz-Carlton Amelia Island – Amelia Island, Florida This course offers Live (in-person) and Livestream (virtual) attendance options. Mayo Clinic’s 33rd Annual Hematology/Oncology Reviews 2024 in Amelia Island, Florida is a comprehensive review of hematology/oncology that focuses on the application of new clinical and research advancements and
Source: ce.mayo.eduCategories: General Medicine News, Hem/OncsTweet-
🚨Announcing the 33rd annual @MayoClinic Florida #Hematology/#Oncology Reviews at Amelia Island Ritz-Carlton (July 2024). Comprehensive conference @MayoCancerCare that focuses on application of new clinical & research advancements over the last year. 👇🏼 https://t.co/bk1zXqkxtO https://t.co/89LZ3FEFxL
-
-
Mashup Score: 12Amer Zeidan, MBBS, MHS, Appointed Inaugural Chief of the Division of Hematologic Malignancies - 10 month(s) ago
Amer Zeidan, MBBS, MHS, has been appointed inaugural chief of the Division of Hematologic Malignancies at Yale Cancer Center.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Amer Zeidan, MBBS, MHS, Appointed Inaugural Chief of the Division of Hematologic Malignancies @Dr_AmerZeidan @YaleCancer #hematology #oncology https://t.co/IksZuA5AlI
-
-
Mashup Score: 2Acute Lymphoblastic Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings - 11 month(s) ago
Shared insight from key opinion leaders on clinical trial data in acute lymphoblastic leukemia from the ASCO 2023 and EHA 2023 Annual Meetings.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
WATCH: A panel of experts discusses key datasets in leukemia that were presented recently at the ASCO 2023 Annual Meeting and the EHA 2023 Congress. @GCC_Cortes #hematology #oncology https://t.co/DJUTuOKzBJ
-
-
Mashup Score: 0
New data suggest the US is on track to experience the projected shortage in the hematology and oncology workforce.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet-
Researchers have projected that the United States is set to experience a shortage in the #hematology and #oncology workforce. New data, published in @JCOOP_ASCO, show a trend in that direction. https://t.co/T6DoovJpy1
-
Iopofosine I 131 Meets MRR End Point in R/R Waldenström Macroglobulinemia #hematology #oncology https://t.co/hEwf6SP5OD